Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment

被引：0
|
作者：
Zorn, Kristin K. [1 ]
机构：
[1] UPMC, Magee Womens Hosp, Gynecol Canc Program, Pittsburgh, PA USA
来源：
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 08期
关键词：
GYNECOLOGIC-ONCOLOGY-GROUP; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; CARCINOMA; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：738 / 740
页数：2
相关论文
共 50 条
  • [31] A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer
    Adachi, S
    Ogasawara, T
    Ito, K
    Koyama, M
    Nagano, T
    Suzuki, A
    Yamada, T
    Nakata, Y
    Ozawa, M
    ONCOLOGY REPORTS, 2001, 8 (02) : 285 - 288
  • [32] First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
    Kristensen, GB
    Vergote, I
    Stuart, G
    Del Campo, JM
    Kaern, J
    Lopez, AB
    Eisenhauer, E
    Aavall-Lundquist, E
    Ridderheim, M
    Havsteen, H
    Mirza, MR
    Scheistroen, M
    Vrdoljak, E
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 : 172 - 177
  • [33] Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer.
    Blank, SV
    Curtin, JP
    Goldman, NA
    Fusco, E
    Lesko, Z
    Hochster, H
    Runowicz, CD
    Wadler, S
    Muggia, FM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 467S - 467S
  • [34] Dose-Dense Paclitaxel With Carboplatin for Advanced Ovarian Cancer: A Feasible Treatment Alternative
    Glaze, Sarah
    Teitelbaum, Lisa
    Chu, Pamela
    Ghatage, Prafull
    Nation, Jill
    Nelson, Gregg
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2013, 35 (01) : 61 - 67
  • [35] The use of pharmacokinetics to improve the treatment of ovarian cancer: combination paclitaxel (Taxol(R))carboplatin
    Calvert, AH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 : 14 - 17
  • [36] Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer
    Havrilesky, LJ
    Alvarez, AA
    Sayer, RA
    Lancaster, JM
    Soper, JT
    Berchuck, A
    Clarke-Pearson, DL
    Rodriguez, GC
    Carney, ME
    GYNECOLOGIC ONCOLOGY, 2003, 88 (01) : 51 - 57
  • [37] Phase II study of weekly paclitaxel carboplatin in the treatment of progressive ovarian cancer.
    Van der Burg, ME
    Vergote, I
    Burger, CW
    van der Gaast, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 463S - 463S
  • [38] The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer
    Hoekstra, Anna V.
    Hurteau, Jean A.
    Kirschner, Carolyn V.
    Rodriguez, Gustavo C.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (03) : 377 - 381
  • [39] A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
    du Bois, A
    Lück, HJ
    Meier, W
    Adams, HP
    Möbus, V
    Costa, S
    Bauknecht, T
    Richter, B
    Warm, M
    Schröder, W
    Olbricht, S
    Nitz, U
    Jackisch, C
    Emons, G
    Wagner, U
    Kuhn, W
    Pfisterer, J
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (17): : 1320 - 1330
  • [40] Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
    Du, Zhenhua
    Ma, Xiaolin
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2015, 10 (03) : 489 - 493
12345